orforglipron and retatrutide Approval Date Eli Lilly Next gen GLP-1 drugs orforglipron

The involvement of DPP-4 in metabolism of endogenous SDF-1 is compatible with the finding that the truncated metabolite, SDF-1 3-67, was present in wild-type mice, but not in animals lacking DPP-4 (62), with this observation being extended in subsequent studies in mice and Rhesus monkeys (63) and in patients with T2DM (64) showing that levels of SDF-1 3-67 were reduced while those of the intact 1-67 form increased concomitantly when DPP-4 activity was inhibited

The extracellular vesicle of depressive patient-derived Escherichia fergusonii induces vagus nerve-mediated neuroinflammation in mice

Myers' Cocktail IV: The gold-standard wellness drip, packed with a perfectly balanced blend of vitamins, calcium, and magnesium for deep hydration, immune support, and a total-body reset

Red Flags: Diapason isn't FDA approved, which means there's no guarantee of safety, effectiveness, or even consistency in what's inside the bottle

Modeling the blood-brain barrier: beyond the endothelial cells

The cardiovascular safety demonstrated by tirzepatide in this analysis and SURPASS-4 paved the way for a large-scale cardiovascular outcomes trial